Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Paratyphi A O-antigen, also known as the O:2 antigen, is a critical surface polysaccharide and a primary component of the lipopolysaccharide (LPS) in the outer membrane of the bacterium [1, 2]. It consists of a repeating trisaccharide backbone composed of rhamnose, mannose, and galactose, with a characteristic paratose side branch that defines its serospecificity [3, 4]. This antigen plays a vital role in bacterial virulence by enabling the pathogen to evade the host's innate immune response, specifically by inhibiting the respiratory burst in phagocytes [9]. As a major immunodominant epitope, it is the focal point for the development of glycoconjugate vaccines aimed at preventing paratyphoid fever, a significant cause of enteric fever globally [1, 5]. Vaccines targeting this antigen work by inducing high titers of bactericidal and opsonophagocytic antibodies that facilitate the clearance of the bacteria [4, 6]. Current therapeutic strategies involve conjugating the O-antigen to carrier proteins like CRM197 or tetanus toxoid to enhance immunogenicity and provide long-lasting protection [7, 12].
Induction of protective humoral immunity, specifically the production of bactericidal and opsonophagocytic antibodies that target the O:2 polysaccharide on the bacterial surface to facilitate pathogen clearance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Paratyphi A O-antigen (O:2 antigen).